Compare BRID & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BRID | DXR |
|---|---|---|
| Founded | 1932 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Foods | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.3M | 59.0M |
| IPO Year | 1995 | 1995 |
| Metric | BRID | DXR |
|---|---|---|
| Price | $6.14 | $9.80 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 2.5K | 2.2K |
| Earning Date | 06-01-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $174,257,000.00 | $1,446,345.00 |
| Revenue This Year | N/A | $44,935.22 |
| Revenue Next Year | N/A | $74.79 |
| P/E Ratio | ★ N/A | $33.83 |
| Revenue Growth | ★ 4.21 | N/A |
| 52 Week Low | $6.08 | $8.56 |
| 52 Week High | $8.62 | $14.76 |
| Indicator | BRID | DXR |
|---|---|---|
| Relative Strength Index (RSI) | 43.33 | 38.46 |
| Support Level | $6.10 | $9.64 |
| Resistance Level | $6.89 | $11.16 |
| Average True Range (ATR) | 0.15 | 0.25 |
| MACD | 0.01 | -0.07 |
| Stochastic Oscillator | 15.54 | 8.30 |
Bridgford Foods Corp manufactures, markets, and distributes frozen and snack food products in the United States. The two business segments are: the processing and distribution of frozen products, and the processing and distribution of snack food products. Its product offerings include meat snacks, breads and rolls, biscuits, and ready-to-eat sandwiches, among others. The company offers frozen food products to the foodservice and retail customers through wholesalers, cooperatives, and distributors; and snack food items to supermarkets, mass merchandise, and convenience retail stores through customer-owned distribution centers, as well as a direct store delivery network. A majority of the company's revenue is derived from the snack food products segment.
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system.